Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Bayer allies with MorphoSys to accelerate drug discovery

Dec. 28, 1999

Transkaryotic Therapies achieves milestone in Aventis collaboration

Dec. 23, 1999

Cambridge NeuroScience issued two patents, three patent allowances

Dec. 23, 1999

Aurora Biosciences announces two ion channel technology agreements

Dec. 23, 1999

Two new patents issued to Helix for drug delivery technology

Dec. 22, 1999

Immune Response acquires T-cell receptor technology from Connetics and Xoma

Dec. 16, 1999

Lexicon Genetics to provide knockout mice for BASF

Dec. 16, 1999

The Rockefeller University designs inhibitors of enzyme involved in melatonin biosynthesis

Dec. 15, 1999

Abgenix and CuraGen to develop genomics-based human antibody drugs

Dec. 15, 1999

Diversa and TerraGen Discovery crosslicense patents

Dec. 14, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...